Clinical Trials on Hematologic Neoplasms in New Zealand
Total 17611 results
-
University of SydneyUniversity of Roma La Sapienza; Australasian Bone Marrow Transplant Recipient... and other collaboratorsRecruiting
-
Malaghan Institute of Medical ResearchRecruitingLymphoma | Leukemia | Myeloma | Temperature Change, Body | Haematological MalignancyNew Zealand
-
University of Auckland, New ZealandWaitemata District Health Board; Counties Manukau Health; Auckland District Health...Completed
-
NYU Langone HealthWithdrawnCancer | Hematological MalignancyUnited States
-
Smart Immune SASRecruitingHematological MalignanciesUnited States
-
University of Auckland, New ZealandNorth Shore Hospital, New Zealand; Waikato Hospital; Gut Cancer Foundation, New...Not yet recruitingIntraductal Papillary Mucinous Neoplasm of PancreasNew Zealand
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
Esanex Inc.Completed
-
ABK BiomedicalCompletedMetastatic Colorectal Cancer | Liver Cancer | Hepatocellular Carcinoma Non-resectableNew Zealand
-
University of Auckland, New ZealandWaitemata District Health Board; Counties Manukau HealthCompletedColorectal Cancer | Surgery | Perioperative Care | ColectomyNew Zealand
-
Middlemore Hospital, New ZealandUnknown
-
Auckland District Health BoardNovartis; University of Auckland, New Zealand; IGENZ, Ltd., AucklandUnknownClear Cell Renal Cell CarcinomaNew Zealand
-
Hangzhou Sumgen Biotech Co., Ltd.RecruitingSG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.Lymphoma | Hematological MalignancyUnited States
-
SanofiCompletedHematological MalignancyGreece, Spain, Peru, Israel, United States, Argentina, Belgium, Brazil, Chile, Finland, France, Italy, Mexico, Russian Federation, Turkey, Ukraine, United Kingdom
-
Provectus PharmaceuticalsCompleted
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
Kangpu Biopharmaceuticals, Ltd.RecruitingHematological MalignanciesUnited States
-
University of Auckland, New ZealandLeukaemia & Blood Cancer New ZealandActive, not recruiting
-
HutchmedRecruitingIsocitrate Dehydrogenase Gene MutationSpain, United States
-
Orsenix LLCCompleted
-
Trans Tasman Radiation Oncology GroupFisher and Paykel Healthcare; Auckland City HospitalCompletedCancer of the Head and NeckNew Zealand
-
Waikato HospitalWellington HospitalRecruitingGlioblastomaNew Zealand
-
AdaptimmuneRecruitingSolid and Hematological MalignanciesUnited States, Spain, Canada, United Kingdom
-
Sight DiagnosticsCompleted
-
AstraZenecaActive, not recruitingPediatric Cancer | Hematological Malignancies | Solid Tumor PediatricSpain, Italy, United States, United Kingdom, France, Netherlands, Germany
-
IncuronTerminatedHematological MalignanciesUnited States
-
Roswell Park Cancer InstituteRecruitingHematopoietic and Lymphoid System NeoplasmUnited States
-
AstraZenecaRecruitingHematological MalignanciesUnited States, Spain, Korea, Republic of, Italy, Japan, Taiwan, Australia, Germany, China
-
Hoffmann-La RocheCompleted
-
Gilead SciencesTerminatedHematological MalignanciesUnited States, United Kingdom
-
Karyopharm Therapeutics IncCompletedHematological MalignanciesUnited States, Denmark, Canada
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Leukemia | Myelodysplastic SyndromeUnited States
-
Effector TherapeuticsTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Myeloma | Hematological MalignancyUnited States
-
Proacta, IncorporatedCompletedUnspecified Adult Solid Tumor, Protocol SpecificNew Zealand
-
University of Auckland, New ZealandCounties Manukau Health; Waikato Hospital; Cancer Trials New ZealandActive, not recruiting
-
Merck Sharp & Dohme LLCActive, not recruitingHematological MalignanciesUnited States, Canada, Brazil, Chile, Denmark, France, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
Novartis PharmaceuticalsTerminated
-
AlexionAchillion, a wholly owned subsidiary of AlexionCompletedParoxysmal Nocturnal HemoglobinuriaNew Zealand, Korea, Republic of, Italy
-
Apellis Pharmaceuticals, Inc.CompletedParoxysmal Nocturnal HemoglobinuriaHong Kong, Thailand, New Zealand, Malaysia
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple MyelomaUnited States, New Zealand
-
Malaghan Institute of Medical ResearchWellington Zhaotai Therapies Limited (WZTL)RecruitingMantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Lymphomas Non-Hodgkin's B-Cell | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL)New Zealand
-
Zealand University HospitalUnknownHematological CancerDenmark
-
Living Cell TechnologiesCompletedParkinson's DiseaseNew Zealand
-
University of Auckland, New ZealandAuckland Medical Research Foundation; Mercia Barnes Trust of the Royal Australian...CompletedPolycystic Ovary SyndromeNew Zealand
-
Living Cell TechnologiesStatistecol Consultants LimitedCompleted
-
Synta Pharmaceuticals Corp.CompletedLymphoma | Leukemia | Hematological Malignancies | Metastatic or Unresectable Solid TumorsUnited States
-
NYU Langone HealthActive, not recruitingHematologic MalignancyUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Matthew DallosBristol-Myers SquibbTerminatedSolid Tumor | Sars-CoV2 | Hematological MalignancyUnited States